2019 Form 10-K (PDF 910KB)
2020 Annual Meeting Notice and Proxy Statement (PDF 466KB)
| Date: | Tuesday, June 16, 2020 |
| Time: | 10:00 a.m., local time |
| Place: | Hilton Garden Inn |
| 14975 Shady Grove Road | |
| Rockville, MD 20850 |
CASI Pharmaceuticals, Inc. is a U.S. NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China.
EVOMELA® (melphalan) for Injection, ZEVALIN® (ibritumomab tiuxetan), and MARQIBO® (vincristine sulfate LIPOSOME injection) are proprietary to Acrotech Biopharma LLC and its affiliates.
© 2020 CASI Pharmaceuticals Inc.
All Rights Reserved.
